Research at Berlin-Buch

The Berlin-Buch Campus is a unique site for medical research and development in Germany. The Max Delbrück Center for Molecular Medicine (MDC), founded in 1992 as a model for clinical research from three institutes of the GDR Academy of Sciences, was the initial driving force for the development of the campus into a research and biotechnology site of supraregional significance. Since 2000, the Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP) has played a major role in this development.

Today, on the 32-hectare site which can look back on a long scientific tradition, institutes for basic medical research, research clinics and biotechnology companies are located in close proximity to each other. Buch's researchers, doctors and entrepreneurs are collaborating in the development of new treatments and diagnostic procedures for cancer, cardiovascular and nervous system diseases.

A modern Congress Center with integrated laboratories on the campus offers multiple opportunities for scientific interaction.

News research

Promoting awareness of health research

During a week-long course at the Gläsernes Labor, 24 teenagers delved into genetics, immunology, and allergic disease. The course marked the beginning of a new collaboration with the Max Delbrück Cent...

more ...

Targeting sleeping tumor cells

Neuroblastoma, a cancer mainly affecting children, is often difficult to treat. A team led by Jan Dörr and Anton Henssen at the Experimental and Clinical Research Center report in “Cancer Discovery,” ...

more ...

Summer Science Day 2025: Uniting under one goal

Lab tours, lively talks, music and awards – Summer Science Day 2025 brought the Max Delbrück Center community together like never before. In addition to food and games, this year's new format created ...

more ...

Events Campus

09.09.2025, 09:00
From Target to Market - The BBA Biotech & Pharma Summer School

The 4-day intensive course provides a comprehensive overview of the entire drug development process in biotechnology and in the pharmaceutical industry – from the idea to the market.

more ...

18.09.2025, 17:00
Talk im Cube: IP Strategies in Biotechnology

We are excited to continue the Talks in the Cube with a further expert discussion focused on Strategies for Intellectual Property Rights in Biotechnology.

more ...